In its guidance, the FDA said it "recognizes that medical device cybersecurity is a shared responsibility among stakeholders including health care facilities, patients, providers, and manufacturers of medical devices. Failure to maintain cybersecurity can result in compromised device functionality, loss of data (medical or personal) availability or integrity, or exposure of other connected devices or networks to security threats. This in turn may have the potential to result in patient illness, injury or death."
The report further noted that "A growing number of medical devices are designed to be networked to facilitate patient care. Networked medical devices, like other networked computer systems, incorporate software that may be vulnerable to cybersecurity threats . . . . manufacturers are encouraged to address cybersecurity throughout the product lifecycle, including during the design, development, production, distribution, deployment and maintenance of the device."
In the wake of the ongoing security concerns surrounding the IoT, security by design is a concept that manufacturers of all types of connected devices, including medical equipment, are taking into consideration.
Suzanne B. Schwartz, Associate director for Science and Strategic Partnerships, at the Center for Devices and Radiological Health, commented in the FDA Voice, that “The best way to combat these threats is for manufacturers to consider cybersecurity throughout the total product lifecycle of a device. In other words, manufacturers should build in cybersecurity controls when they design and develop the device to assure proper device performance in the face of cyber threats, and then they should continuously monitor and address cybersecurity concerns once the device is on the market and being used by patients.”
The endpoint security approach addresses several vulnerability areas:
physical security to prevent uncontrolled changes to or the removal of the endpoint
root of trust to provide confidence on the endpoint identity
integrity protection to ensure that the endpoint is in the configuration that enables it to perform its functions predictably
access control to ensure that proper identification, authentication and authorization protocols are performed
secure configuration and management control updates of security policies and configurations
monitoring and analysis including integrity checking, detecting malicious usage patterns or denial of service activities, and enforcing security policies and analytics
data protection to control data integrity, confidentiality and availability
security models and policies governing the implementation of security functions.
At Wibu-Systems, one of our major areas of focus is on the protection of medical device endpoints, where vulnerabilities may permit the unauthorized access, modification, or misuse. Our approach is to build multi-layered security measures directly into the design of sensors, PLCs, embedded devices, virtual systems or other connected endpoints.
For more details, Oliver Winzenried, President and CEO of WIBU-SYSTEMS AG, further explains the risks and rewards of endpoint security in his article, Protecting endpoint security of medical systems, published in Medical Device Developments magazine.
Vice President Sales USA
Terry Gaul is a sales and business development professional with extensive experience in the software and technology sectors. He has been involved with software protection and licensing technologies for more than 20 years and currently serves as Vice President of Sales at Wibu-Systems USA. When he is not helping customers with software licensing, Terry typically can be found coaching his daughters' soccer teams or camping with his family on the Maine coast.